EDITAS MEDICINE INC (EDIT)
US28106W1036 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 69.23M | 123.65M | 141.50M | 203.50M | 139.70M | |||
| Marketable Securities | 226.94M | 199.46M | 202.80M | 296.30M | 262.40M | |||
| Receivables | 245.00K | 10.19M | 5.10M | 300.00K | 6.00M | |||
| Other Current Assets | 9.14M | 7.53M | 7.30M | 7.20M | 10.90M | |||
| Total Current Assets | 305.56M | 340.83M | 356.80M | 507.30M | 419.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 44.70M | 45.71M | 59.20M | 43.30M | 39.10M | |||
| Investments And Advances | 80.61M | 104.02M | 93.10M | 120.10M | 109.70M | |||
| Other Non-Current Assets | 9.49M | 8.59M | 5.30M | 6.80M | 4.70M | |||
| Total Non-Current Assets | 134.79M | 158.32M | 157.50M | 170.20M | 153.50M | |||
| TOTAL ASSETS | 440.35M | 499.15M | 514.30M | 677.50M | 572.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 43.84M | 46.73M | 42.40M | 30.50M | 30.90M | |||
| Accounts Payable | 7.97M | 8.27M | 9.50M | 5.10M | 6.40M | |||
| Other Current Liabilities | 14.68M | 8.22M | 8.20M | 11.30M | 20.90M | |||
| Total Current Liabilities | 66.49M | 63.22M | 60.10M | 46.90M | 58.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 79.46M | 86.84M | 93.50M | 77.00M | 120.80M | |||
| Total Non-Current Liabilities | 79.46M | 86.84M | 93.50M | 76.90M | 120.80M | |||
| TOTAL LIABILITIES | 145.95M | 150.06M | 153.60M | 123.80M | 179.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.29B | -1.23B | -1.08B | -857.70M | -665.20M | |||
| Additional Paid In Capital | 1.59B | 1.58B | 1.44B | 1.41B | 1.06B | |||
| Common Shares | 8.00K | 8.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -326.00K | 198.00K | -3.60M | -500.00K | 0.00 | |||
| Shares Outstanding | 82.23M | 81.77M | 68.80M | 68.40M | 62.60M | |||
| Tangible Book Value per Share | 3.58 | 4.27 | 5.24 | 8.09 | 6.29 | |||
| Total Shareholders' Equity | 294.40M | 349.10M | 360.70M | 553.60M | 393.60M | |||
| TOTAL LIABILITIES AND EQUITY | 440.35M | 499.15M | 514.30M | 677.50M | 572.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 4.60 | 5.39 | 5.94 | 10.82 | 7.20 | |||
| Return On Assets (ROA) | -37.73% | -30.70% | -42.86% | -28.41% | -20.25% | |||
| Return On Equity (ROE) | -56.43% | -43.89% | -61.11% | -34.77% | -29.47% | |||
All data in USD